Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Major pollen allergen Phl p 1 is the primary immunodominant protein found in Timothy grass (Phleum pratense) pollen and is classified as a group 1 grass allergen (UniProt: P43213). Biologically, it functions as a beta-expansin, an enzyme-like protein that facilitates plant cell wall loosening by disrupting hydrogen bonds between cellulose microfibrils and matrix polysaccharides during pollen germination. In clinical medicine, Phl p 1 is a major driver of Type I hypersensitivity, with over 90% of grass pollen-allergic patients exhibiting specific IgE reactivity to this molecule. It serves as a central therapeutic target in allergen-specific immunotherapy (AIT), where it is administered to patients in standardized doses to induce immunological tolerance (FDA: STN 125444). The therapeutic mechanism involves shifting the immune response from a Th2-mediated allergic state to a Th1 and regulatory T-cell (Treg) profile, which promotes the production of protective IgG4 blocking antibodies. Consequently, Phl p 1 is essential for both the molecular diagnosis of grass pollen allergy and the formulation of desensitization treatments such as sublingual tablets and subcutaneous injections.
Induction of peripheral T-cell tolerance, stimulation of regulatory T-cells (Tregs), and production of allergen-specific IgG4 blocking antibodies to inhibit IgE-mediated mast cell degranulation.
3 more in the full profile.
Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major pollen allergen Phl p 1 (Phl p 1).